KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma
[Paper-level Aggregated] PMCID: PMC7467277
Evidence Type(s): Oncogenic
Summary: Mutation: chr8:208343-27992852 | Summary: The deletion observed on chromosome 8p, specifically spanning the region chr8:208343-27992852, is classified as a somatic copy number alteration (CNA) that contributes to tumor development or progression.
Gene→Variant (gene-first): NA:chr8:208343-27992852
Genes: NA
Variants: chr8:208343-27992852